These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24346231)

  • 1. Activation of TREK-1 by morphine results in analgesia without adverse side effects.
    Devilliers M; Busserolles J; Lolignier S; Deval E; Pereira V; Alloui A; Christin M; Mazet B; Delmas P; Noel J; Lazdunski M; Eschalier A
    Nat Commun; 2013; 4():2941. PubMed ID: 24346231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Gβγ-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward.
    Hoot MR; Sypek EI; Reilley KJ; Carey AN; Bidlack JM; McLaughlin JP
    Behav Pharmacol; 2013 Apr; 24(2):144-52. PubMed ID: 23412114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.
    Rashid MH; Inoue M; Toda K; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):380-7. PubMed ID: 14718584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of Phα1β, a peptide from the venom of the spider Phoneutria nigriventer, on the analgesic and adverse effects caused by morphine in mice.
    Tonello R; Rigo F; Gewehr C; Trevisan G; Pereira EM; Gomez MV; Ferreira J
    J Pain; 2014 Jun; 15(6):619-31. PubMed ID: 24607814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.
    Kliewer A; Schmiedel F; Sianati S; Bailey A; Bateman JT; Levitt ES; Williams JT; Christie MJ; Schulz S
    Nat Commun; 2019 Jan; 10(1):367. PubMed ID: 30664663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance.
    Shavit Y; Wolf G; Goshen I; Livshits D; Yirmiya R
    Pain; 2005 May; 115(1-2):50-9. PubMed ID: 15836969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J
    Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
    Freye E; Latasch L
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.
    Johnson EE; Chieng B; Napier I; Connor M
    Br J Pharmacol; 2006 Aug; 148(7):947-55. PubMed ID: 16783402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic dissociation of morphine analgesia from hyperalgesia in mice.
    Marrone GF; Le Rouzic V; Varadi A; Xu J; Rajadhyaksha AM; Majumdar S; Pan YX; Pasternak GW
    Psychopharmacology (Berl); 2017 Jun; 234(12):1891-1900. PubMed ID: 28343361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans.
    Mogil JS; Ritchie J; Smith SB; Strasburg K; Kaplan L; Wallace MR; Romberg RR; Bijl H; Sarton EY; Fillingim RB; Dahan A
    J Med Genet; 2005 Jul; 42(7):583-7. PubMed ID: 15994880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine.
    Gilbert AK; Hosztafi S; Mahurter L; Pasternak GW
    Eur J Pharmacol; 2004 May; 492(2-3):123-30. PubMed ID: 15178355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Mas oncogene-related gene (Mrg) C receptors enhances morphine-induced analgesia through modulation of coupling of μ-opioid receptor to Gi-protein in rat spinal dorsal horn.
    Wang D; Chen T; Zhou X; Couture R; Hong Y
    Neuroscience; 2013 Dec; 253():455-64. PubMed ID: 24042038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effect of intrathecal loperamide: role of mu-opioid receptor and calcium channels.
    Kumar R; Reeta KH; Ray SB
    Eur J Pharmacol; 2012 Dec; 696(1-3):77-82. PubMed ID: 23022331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions.
    Mori T; Shibasaki Y; Matsumoto K; Shibasaki M; Hasegawa M; Wang E; Masukawa D; Yoshizawa K; Horie S; Suzuki T
    J Pharmacol Exp Ther; 2013 Oct; 347(1):91-9. PubMed ID: 23902939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice.
    Yoshida M; Ohdo S; Takane H; Tomiyoshi Y; Matsuo A; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1200-5. PubMed ID: 12626644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.